1-4 of 4
Juan Berlanga
Close
Sort by
Journal Articles

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia

Clinical Trials & Observations
Mariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, Alfons Navarro, Granada Perea, Jordi Esteve, Rosa Artells, Miquel Granell, Juan Berlanga, Josep M. Ribera, Javier Bueno, Andreu Llorente, Ramon Guardia, Mar Tormo, Pio Torres, Josep F. Nomdedéu, Emili Montserrat, Jordi Sierra, for CETLAM
Journal: Blood
Blood (2006) 107 (12): 4871–4879.
https://doi.org/10.1182/blood-2005-08-3272
Published: 2006
Journal Articles

Use of Granulocyte Colony-Stimulating Factor (G-CSF) Together with Induction and Intensification Chemotherapy (CT) in Adults with Primary Acute Myeloid Leukemia (AML).

Salut Brunet, Granada Perea, Josep M. Ribera, Jordi Esteve, Mar Tormo, Juan Berlanga, Javier Bueno, Andreu Llorente, Jose M. Moraleda, Ramon Guardia, Joan Besalduch, Pio Torres, Maria Paz Queipo de Llano, Josep M. Marti, Carmen Pedro, Joan Bargay, Josep M. Sanchez, Pilar Vivancos, Evaristo Feliu, Emili Montserrat, Jorge Sierra
Journal: Blood
Blood (2005) 106 (11): 1855.
https://doi.org/10.1182/blood.V106.11.1855.1855
Published: 2005
Journal Articles

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC).

Granada Perea, MD, Adriana Lasa, PhD, Anna Aventin, MD, Alicia Domingo, MD, Neus Villamor, MD, Maria Paz Queipo de LLano, MD, Andreu Llorente, MD, Jordi Junca, MD, Carlos Palacios, MD, Cristalina Fernandez, MD, Miquel Guallart, MD, Llorens Font, MD, Mar Tormo, MD, Lourdes Florensa, MD, Joan Bargay, MD, Josep M. Marti, MD, Pilar Vivancos, MD, Pio Torres, MD, Juan Berlanga, MD, Salut Brunet, MD, Jorge Sierra, MD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2004) 104 (11): 2989.
https://doi.org/10.1182/blood.V104.11.2989.2989
Published: 2004
Journal Articles

Germline Polymorphisms Provide Strong Prognostic Information in Intermediate Risk Acute Myeloblastic Leukemia (AML).

Alvaro Urbano-Ispizua, MD, Salut Brunet, MD, Mariano Monzo, MD, PhD, Granada Perea, MD, Alfons Navarro, PhD, Jordi Esteve, MD, Juan Berlanga, MD, Josep-Maria Ribera, MD, Javier Bueno, MD, Andreu Llorente, MD, Juan Besalduch, MD, Ramon Guardia, MD, Mar Tormo, MD, Carmen Pedro, MD, Juan-Maria Sanchez, MD, Pio Torres, MD, Maria-Paz Queipo de Llano, MD, Llorens Font, MD, Jose-Maria Moraleda, MD, Josep-Maria Marti, MD, Pilar Vivancos, MD, Maria-Jesus Peñarubia, MD, Josep Nomdedeu, MD, Emili Montserrat, MD, Jorge Sierra, MD
Journal: Blood
Blood (2004) 104 (11): 398.
https://doi.org/10.1182/blood.V104.11.398.398
Published: 2004